MA, E., A, M., F, M., WK, A., DS, A., E, F., . . . MA, S. (2025). Oncogenic EME1 promotes tumor progression and immune modulation in human cancers with therapeutic targeting potential. Discover oncology, 16(1), 1855. https://doi.org/10.1007/s12672-025-03631-8
Chicago Style (17th ed.) CitationMA, Eldeen, et al. "Oncogenic EME1 Promotes Tumor Progression and Immune Modulation in Human Cancers with Therapeutic Targeting Potential." Discover Oncology 16, no. 1 (2025): 1855. https://doi.org/10.1007/s12672-025-03631-8.
MLA (9th ed.) CitationMA, Eldeen, et al. "Oncogenic EME1 Promotes Tumor Progression and Immune Modulation in Human Cancers with Therapeutic Targeting Potential." Discover Oncology, vol. 16, no. 1, 2025, p. 1855, https://doi.org/10.1007/s12672-025-03631-8.